文献速递神经肿瘤

胶质母细胞瘤患者的抑郁症状和执行功能与生存的关系

Depressive symptoms and executive function in relation to survival in patients with glioblastoma.
PubMed 文献 · J Neurooncol · 2019-01-24

本研究纳入102例胶质母细胞瘤患者,术后完成贝克抑郁量表第二版(BDI-II)和连线测验B部分(TMTB),按中位数分割分组,用Kaplan-Meier法、log-rank检验和Cox回归分析生存差异。结果显示抑郁症状和执行功能受损均独立与较短的总生存期(OS)相关,常规神经心理评估可能有助于细化预后并促进心理与认知干预。

要点

  • 抑郁症状和执行功能受损均独立与胶质母细胞瘤患者较短的总生存期相关。
  • 四组中位OS分别为22.8、16.6、14.8和10.8个月,均低于无抑郁且无执行功能受损组。
  • 常规评估情绪和认知可能有助于细化预后并促进心理与认知干预。

核心结论

  • 抑郁症状和执行功能受损均独立与胶质母细胞瘤患者较短的总生存期相关。
  • 作者认为常规神经心理评估情绪和认知可能有助于细化预后并促进心理与认知干预,从而改善患者生活质量,并需要进一步研究。

研究设计与样本

  • 研究纳入102例胶质母细胞瘤患者,术后完成神经心理评估,包括贝克抑郁量表第二版(BDI-II)和连线测验B部分(TMTB)。
  • 采用中位数分割确定BDI-II抑郁症状升高和TMTB执行功能受损的界值,将患者分为四组:低抑郁症状/低执行功能受损(- Dep/- Imp,N=23)、高抑郁症状/低执行功能受损(+ Dep/- Imp,N=28)、低抑郁症状/高执行功能受损(- Dep/+Imp,N=28)、高抑郁症状/高执行功能受损(+ Dep/+Imp,N=23)。
  • 采用Kaplan-Meier法、log-rank检验和Cox回归分析组间生存差异。

主要发现

  • 相对于- Dep/- Imp组(中位OS=22.8个月),其他各组中位OS均更短:+ Dep/- Imp组OS=16.6个月,- Dep/+Imp组OS=14.8个月,+Dep/+Imp组OS=10.8个月,所有p < .05。
  • 除KPS和年龄外,各组临床和人口学特征分布无差异。
  • 在Cox回归模型中,KPS和年龄均未改变BDI-II和TMTB对OS的独立效应。

临床怎么用

  • 作者认为常规神经心理评估情绪和认知可能有助于细化预后并促进心理与认知干预,从而改善患者生活质量,并需要进一步研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Depression and neurocognitive function, particularly executive functioning (EF), have been associated with overall survival (OS) in patients with glioblastoma (GBM). However, the combined effect of depressive symptoms and impaired EF upon OS has not been reported. METHODS: Patients with GBM (N = 102) completed neuropsychological assessment postoperatively, including the Beck Depression Inventory-Second Edition (BDI-II) and the Trail Making Test Part B (TMTB). Median splits were used to determine cut-points denoting elevated depressive symptoms on the BDI-II and impaired EF on TMTB. Patients were stratified into four groups: low depressive symptoms/low EF impairment (- Dep/- Imp; N = 23), high depressive symptoms/low EF impairment (+ Dep/- Imp; N = 28), low depressive symptoms/high EF impairment (- Dep/+Imp; N = 28), and high depressive symptoms/high EF impairment (+ Dep/+Imp; N = 23). The Kaplan-Meier method, log-rank test, and Cox regression were used to examine differences in survival between groups. RESULTS: Relative to - Dep/- Imp patients (median OS = 22.8 months), median OS in all other patient groups was shorter (+ Dep/- Imp OS = 16.6; - Dep/+Imp OS = 14.8; +Dep/+Imp OS = 10.8; all p < .05). With the exception of KPS and age, groups did not differ in distribution of clinical and demographic characteristics. Neither KPS nor age modified the independent effect of BDI-II and TMTB on OS in Cox regression models. CONCLUSIONS: The presence of depressive symptoms and impaired EF are independently associated with shorter OS in patients with GBM. These results suggest that routine neuropsychological assessment of mood and cognition may help refine prognosis and facilitate initiation of psychological and cognitive interventions, which can improve patient quality of life, and warrants further investigation.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Noll KR, Sullaway CM, Wefel JS, et al. Depressive symptoms and executive function in relation to survival in patients with glioblastoma. J Neurooncol. 2019. PMID: 30680509. doi:10.1007/s11060-018-03081-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。